Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
Darrell E White,1 Yang Zhao,2 Hemalatha Jayapalan,3 Pattabhi Machiraju,3 Ramu Periyasamy,3 Abayomi Ogundele2 1SkyVision Centers, Westlake, OH, USA; 2Medical Affairs, Sun Pharmaceutical Industries, Princeton, NJ, USA; 3Medical Services, Indegene, Inc, Bangalore, IndiaCorrespondence: Abayomi OgundeleM...
Saved in:
Main Authors: | White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/8db4b64bb83a47058d929b6e1e983ae5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
by: White DE, et al.
Published: (2020) -
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
by: White DE, et al.
Published: (2019) -
Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears
by: Epitropoulos AT, et al.
Published: (2020) -
Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
by: Godin MR, et al.
Published: (2017) -
Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review
by: Atallah RT, et al.
Published: (2019)